Reply

Affiliations

¹ Alaska Native Medical Center, CDC Arctic Investigations Program, Anchorage, AK.
² Arctic Investigations Program, National Center for Preparedness, Detection and Control of Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK.

Comment

Jospehine Simonetti et al. Hepatology. 2016 Aug.

. 2016 Aug;64(2):690-1.

doi: 10.1002/hep.28501. Epub 2016 Apr 5.

¹ Alaska Native Medical Center, CDC Arctic Investigations Program, Anchorage, AK.
² Arctic Investigations Program, National Center for Preparedness, Detection and Control of Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK.

No abstract available

Comment on

Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus.
Simonetti J, Bulkow L, McMahon BJ, Homan C, Snowball M, Negus S, Williams J, Livingston SE. Simonetti J, et al. Hepatology. 2010 May;51(5):1531-7. doi: 10.1002/hep.23464. Hepatology. 2010. PMID: 20087968
Correction.
[No authors listed] [No authors listed] Hepatology. 2015 Oct;62(4):1330. doi: 10.1002/hep.27974. Epub 2015 Aug 7. Hepatology. 2015. PMID: 26418199 No abstract available.
Incidence of hepatocellular carcinoma after seroclearance is not reduced.
Tan CK. Tan CK. Hepatology. 2016 Aug;64(2):690. doi: 10.1002/hep.28505. Epub 2016 Mar 29. Hepatology. 2016. PMID: 26891112 No abstract available.